The escalating threat of antifungal resistance stemming from Trichosporon asahii (T. asahii)
biofilms necessitates the pursuit of innovative therapeutic strategies. Among these …

Dermatophyte biofilms frequently count for inadequate responses and resistance to
standard antifungal treatments, resulting in refractory chronic onychomycosis infection …

Background and Objectives Trichosporiosis is an opportunistic infection that includes
superficial infections, white piedra, hypersensitivity pneumonitis, and invasive …

Biofilm formation is a critical event in the pathogenesis and virulence of fungal infections
caused by Candida albicans, giving rise to about a 1000-fold increase in the resistance to …

Abstract Background Biofilm-associated Candida albicans (C. albicans) infections are hard
to cure due to their high levels of resistance to antifungal agents. Photodynamic therapy …

Opportunistic fungal pathogens may cause superficial or serious invasive infections,
especially in immunocompromised and debilitated patients. Invasive mycoses represent an …

Aspergillus fumigatus biofilm development results in enhanced pathogenicity and treatment
resistance. Most contemporary antibiotics, however, are unable to eliminate biofilms. In …

Fungal infections are increasing in prevalence worldwide, especially in
immunocompromised individuals. Given the emergence of drug-resistant fungi and the fact …

Fungal pathogens and their associated infections present a growing challenge to global
public health. Among these pathogens, Candida auris has emerged as a highly hazardous …

Staphylococcus aureus (S. aureus) is a common human pathogen, which causes pyogenic
and systemic infections. S. aureus infections are difficult to eradicate not only due to the …